Senior executive in biotechnology and financial services. Return on equity oriented CEO with extensive P&L experience and background in raising capital and mergers and acquisitions. Specialties: Biotechnology, investment banking, insurance and financial services.
President and CEO @ I assumed leadership of this highly promising biotechnology company in late 2011. Trigemina has two compounds that address pain through intranasal